May 23, 2025 By: Annie Scolamieri, Aditi Doshi, Pamela Engelhart, Gregory Lief, and Yakir Siegal Evolution v. Revolution: The Impact of ‘Most Favored Nation’ Pricing
May 16, 2025 By: Courtney McGee, Nolan Webb, Gregory Lief, and Yakir Siegal Recognizing Mental Health Awareness Month
March 28, 2025 By: Gregory Lief, Yakir Siegal, and Vivian Chen The Future of Biopharma: Reflections on MassBio’s State of Possible 2025 Conference
March 27, 2025 By: Rachel Sachs, Courtney McGee, Nellie Stidham, Jenna Charles Carson, Aditi Doshi, and Michael Nguyen Reflections on the Simmons Leadership Conference 2025
February 26, 2025 By: Aditi Doshi, Pamela Engelhart, Annie Scolamieri, Gregory Lief, and Yakir Siegal Addressing Rare Disease Care Pathways
February 18, 2025 By: Pamela Engelhart, Aditi Doshi, Annie Scolamieri, Yakir Siegal, and Gregory Lief Navigating Policy Whiplash: Implications for Biopharma